RTL
NTLA icon

Red Tortoise LLC’s Intellia Therapeutics NTLA Stock Holding History

Red Tortoise LLC’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-250
Closed -$4.32K – 619
2025
Q3 		$4.32K Hold
250
– – ﹤0.01% 405
2025
Q2 		$2.35K Buy
+250
New +$2.05K ﹤0.01% 499
2025
Q1 		– Sell
-141
Closed -$1.64K – 625
2024
Q4 		$1.64K Buy
+141
New +$2.2K ﹤0.01% 552

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Red Tortoise LLC's NTLA Position: Q4 2025 in Review

Red Tortoise LLC sold out of Intellia Therapeutics (NTLA) in Q4 2025, closing a stake of 250 shares — an estimated $4.32K sold.

Red Tortoise LLC first reported a position in NTLA in Q4 2024 and held it in 3 quarters. The position peaked at $4.32K in Q3 2025. 293 funds tracked by Wall St. Rank hold NTLA as of Q4 2025.

  • Red Tortoise LLC reported no remaining Intellia Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Red Tortoise LLC sold 250 Intellia Therapeutics shares in Q4 2025, an estimated $4.32K.
  • Red Tortoise LLC first reported a position in Intellia Therapeutics in Q4 2024 and held it in 3 quarters.
  • Red Tortoise LLC's Intellia Therapeutics position peaked at $4.32K in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2025.

Based on Red Tortoise LLC's 13F filing for Q4 2025, filed 22 Jan 2026.